Jeff joined LifeArc in 2010 and leads a team of multidisciplinary biologists supporting early-phase preclinical drug discovery and target validation. The teams are involved in reagent generation, assay development, hit ID, iterative profiling, later stage optimisation and bespoke in-depth mechanistic interrogation for small molecules and therapeutic antibodies, as well as non-traditional modalities.

Jeff has a passion for delivering safe and efficacious medicines, not least through reducing late-stage drug attrition.

He is a pharmacologist and prior to joining LifeArc spent 20 years as a neuroscientist with GSK, where he supported the development of therapeutics for both psychiatric and neurodegenerative disease.


Message Jeff

  • Hidden
  • Hidden
  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email dataprivacy@lifearc.org.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • This field is for validation purposes and should be left unchanged.
Back to our people